Diagnosis of the mitochondrial encephalomyopathies

Current Opinion in Rheumatology

Volumn 9, Issue 6, 1997, Pages 496-503

  Shanske, Sara ^a   DiMauro, Salvatore ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

CELL ORGANELLE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALOMYOPATHY; ENZYME DEFECT; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

EID: 0030731867     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199711000-00004     Document Type: Review

References (36)

1. Bonilla E, Sciacco M, Tanji K, Sparaco M, Petruzzella V, Moraes CT: New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol 1992, 2:113-119.
2. De Vivo DC, Hirano M, DiMauro S: Mitochondrial disorders. In Handbook of Clinical Neurology, vol 22. Edited by Moser HW. Amsterdam: Elsevier; 1996:389-444. Review of mitochondrial metabolism and description of biochemical abnormalities, including defects of the carnitine cycle, fatty acid oxidation, and pyruvate metabolism.
3. Taroni F, Verderio E, Dworzak F, Willems PJ, Cavadini P, DiDonato S: Identification of a common mutation in the carnitine palmitoyltrasferase II gene in familial recurrent myoglobinuria patients. Nat Genet 1993, 4:314-319.
4. DiMauro S, Bonilla E: Mitochondrial encephalomyopathies. In The Molecular and Genetic Basis of Neurological Disease, edn 2. Edited by Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL Boston: Butterworth-Heinemann; 1997:201-235. Review of the morphologic, biochemical, and molecular genetic features of the mitochondrial encephalomyopathies. Emphasis is on disorders of the respiratory chain and mtDNA abnormalities.
5. Bresolin N, Zoviani M, Bonilla E, Miller RH, Leech RW, Shanske S, Nakagawa M, DiMauro S: Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology 1985, 35:802-812.
6. DiMauro S, Nicholson JF, Hays AP, Eastwood AB, Papadimitriou A, Koenigsberger R, DeVivo DC: Benign infantile mitochondrial myopathy due to reversible cytocrome c oxidase deficiency. Ann Neurol 1983, 14:226-234.
7. Tritschler HJ, Bonilla E, Lombes A, Andreetta F, Servidei S, Schneyder B, Miranda AF, Schon EA, Kadenbach B, DiMauro S: Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology 1991, 41:300-305.
8. DiMauro S, Servidei S, Zeviani M, DiRocco M, De Vivo DC, DiDonato S, Uziel G, Berry K, Hoganson G, Johnsen SD, Johnson PC: Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987, 22:498-506.
9. Van Coster R, Lombes A, De Vivo DC, Chi TL, Dodson WE, Rothman S, Orrechio EJ, Grover W, Berry GT, Schwartz JF, et al.: Cytochrome c oxidase-associated Leigh syndrome: phenotypic features and pathogenetic speculations. J Neurol Sci 1991, 104:97-111.
10. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995, 11:144-148.
11. Holt IJ, Harding AE, Morgan Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
12. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas II LJ, Nikoskelainen EK: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
13. Lys mutation. Cell 1990, 61:931-937.
14. Servidei S: Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 1997, 7:XII-XVII. Up-to-date listing of reported defects of mtDNA, describing the specific mutations, gene locations, and mode of inheritance, with a key reference for each.
15. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
16. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481-488.
17. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Simonetti S, Angelini C, Donati A, Garcia C, et al.: MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992, 31:391-398.
18. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, Schon EA, Bonilla E, DiMauro S: Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993, 3:43-50.
19. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y-I, et al.: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994, 330:962-968.
20. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990, 46:428-433.
21. Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JTR, Wherret J, Smith C, Rudd N, Petrova-Benedict R, Robinson BH: Heteroplasmic mitochondrial DNA mutation (T to G) at 8993 can cause Leigh disease when the percentage of abnormal mt DNA is high. Am J Hum Genet 1992, 50:852-858.
22. Shoffner JM, Fernhoff PM, Krawiecki NS, Caplan DB, Holt PJ, Koontz DA, Takei Y, Newman NJ, Ortiz RG, Polak M, et al.: Subacute necrotizlng encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 1992, 42:2168-2174.
23. Santorelli FM, Shanske S, Macaya A, De Vivo DC, DiMauro S: The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh syndrome. Ann Neurol 1993, 34:827-834.
24. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S: A novel mitochondrial ATPase 6 point mutation in familiar bilateral striatal necrosis. Ann Neurol 1995, 38:468-472.
25. Santorelli FM, Mak S-C, Vazquez-Memije M, Shanske S, Kranz-Eble P, Jain KD, Bluestone DL, De Vivo D, DiMauro S: Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996, 39:914-917.
26. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, et al.: Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989, 320:1293-1299.
27. Larsson N-G, Holme E, Kristiansson B, Oldfors A, Tulinius M: Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pedriatr Res 1990, 28:131-136.
28. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ: Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Mol Genet 1993, 2:1619-1624.
29. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S: An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989, 339:309-311.
30. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S: Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996, 46:1329-1334.
31. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE, et al.: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994, 44:721-727.
32. Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, Griggs RC, Mendell JR, Hays AP, Bertorini TE, et al.: Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 1996, 39:789-795. This study confirmed the pre-sence of multiple deletions in mtDNA in some patients with sporadic inclusion body myositis. Although neither the origin nor the pathogenic significance of these multiple deletions is known, it is interesting that they were detected in a high percentage (73%) of patients as compared with appropriate controls.
33. Moraes CT, Ricci E, Arnaudo E, Bonilla E, DiMauro S, Schon EA: Quantitative defects of mitochondrial DNA. In Mitochondrial DNA in Human Pathology. Edited by DiMauro S, Wallace DC. New York: Raven Press; 1993:97-108.
34. Calvani M, Koverech A, Caruso G: Treatment of mitochondrial diseases. In Mitochondrial DNA in Human Pathology. Edited by DiMauro S, Wallace DC. New York: Raven Press; 1993:173-198.
35. DiMauro S: Mitochondrial encephalomyopathies: what next? J Inherit Metab Dis 1996, 19:489-503. Brief summary pointing out areas in the field where there are still many unsolved problems and where future research will be directed, including nDNA mutations, the pathophysiology of mtDNA-related disorders, therapy, and genetic counseling.
36. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL: Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995, 45:1193-1198.